The Hormonal Loop and Ovulation
How follicle-stimulating hormone and luteinizing hormone coordinate the menstrual cycle and fertility windows.
8 min read · Published June 14, 2026 · Reference: Endocrine Society patient resources
Medically Reviewed By Dr. Amara Rao · MBBS, MD (Obstetrics & Gynaecology)
The menstrual cycle begins with the brain signaling the ovaries via follicle-stimulating hormone (FSH). Ovarian follicles mature and produce estrogen, which thickens the uterine lining and triggers the mid-cycle luteinizing hormone (LH) surge.
Ovulation typically occurs about 24–36 hours after the LH surge. The released egg remains fertilizable for roughly 12–24 hours, while sperm may survive several days in reproductive tract fluid—creating a wider fertile window than ovulation day alone.
After ovulation, the corpus luteum produces progesterone to support the lining. If pregnancy does not occur, hormone levels fall and menstruation begins. Cycle length variability is common, especially in teens and perimenopause.
Tracking cervical mucus, basal body temperature, or urinary LH kits can improve body literacy. These methods are educational and may support fertility awareness goals but require training for contraceptive use.
Reading the hormonal loop
The menstrual cycle is a feedback loop between the brain and the ovaries. Rising estrogen in the first half thickens the uterine lining and eventually triggers a surge of luteinizing hormone, which releases an egg. After ovulation, progesterone dominates and prepares the body for a possible pregnancy; if none occurs, hormone levels fall and menstruation begins.
Cycle length varies between individuals and even month to month. The luteal phase after ovulation is relatively fixed at around 12 to 14 days, while the timing of ovulation itself shifts more, which is why the fertile window is not the same day for everyone.
Signs you can actually observe
Around ovulation, cervical mucus typically becomes clearer, stretchier, and more slippery, resembling raw egg white. Basal body temperature rises slightly after ovulation and stays up until the next period. Some people notice mild one-sided pelvic twinges. Tracking two or three of these signs together is far more reliable than any single indicator.
When to check with a clinician
Cycles shorter than 21 days, longer than 35 days, highly irregular timing, or the absence of periods deserve evaluation, as they can point to conditions such as thyroid disorders or PCOS that are very treatable once identified.
The Four Hormones That Govern the Ovulatory Loop
Ovulation is the product of a precisely timed conversation between four hormones: gonadotropin-releasing hormone (GnRH) from the hypothalamus, follicle-stimulating hormone (FSH) and luteinising hormone (LH) from the anterior pituitary, and oestradiol and progesterone from the ovaries. GnRH pulses in a pulsatile fashion — the frequency and amplitude of these pulses determine whether FSH or LH is preferentially secreted. This pulsatile nature is why continuous GnRH exposure (as with some medical treatments) paradoxically suppresses rather than stimulates ovulation.
Rising oestradiol from the developing follicle normally exerts negative feedback on FSH and LH, keeping levels controlled. But uniquely at mid-cycle, sustained high oestradiol flips to a brief positive feedback effect, triggering the LH surge — the sharp spike that causes the dominant follicle to rupture and release an egg within thirty-six to forty-four hours. This LH surge is the basis for over-the-counter ovulation predictor kits (OPKs), which detect the surge in urine and indicate the window of peak fertility.
Follicular Development: From Recruitment to Dominance
Each ovarian cycle begins with the simultaneous recruitment of a cohort of antral follicles — small fluid-filled sacs, each containing an immature egg — that have been developing for several months in a hormone-independent growth phase. Rising FSH in the early follicular phase selects and nourishes this cohort. One follicle, the dominant follicle, emerges by cycle day five to seven because it has the greatest sensitivity to FSH; it accelerates its oestradiol production, suppresses FSH (causing the others to regress), and grows to an average diameter of 20–24 mm before rupture.
The egg inside the dominant follicle (the oocyte) completes its first meiotic division just before ovulation, a step paused since before birth. This creates a secondary oocyte and a small polar body. The second meiotic division completes only if the egg is fertilised by a sperm — another remarkable aspect of human reproduction. The oocyte itself remains viable for fertilisation for twelve to twenty-four hours after ovulation, which is why the timing window for conception is relatively narrow.
The Corpus Luteum and the Luteal Phase
After ovulation the ruptured follicle collapses and undergoes a rapid transformation, becoming the corpus luteum — a temporary endocrine gland that produces substantial progesterone and lesser amounts of oestradiol for approximately twelve to sixteen days. Progesterone prepares the endometrium for implantation by making it thick, vascularised, and secretory, and it also raises basal body temperature by 0.2–0.5 °C — the basis of the basal body temperature (BBT) method of fertility tracking.
If implantation occurs, the embryo secretes human chorionic gonadotropin (hCG), which rescues the corpus luteum from its programmed demise, sustaining progesterone production until the placenta takes over at around ten weeks of gestation. If no implantation occurs, the corpus luteum degenerates, progesterone and oestradiol fall sharply, the endometrium is shed as menstruation, and FSH begins rising again to start the next cycle. This feedback loop is elegant in its self-regulation.
Tracking Ovulation: Methods and Their Accuracy
Basal body temperature tracking involves measuring temperature immediately upon waking, before any activity, and charting it daily. A sustained rise of at least 0.2 °C over three consecutive days confirms that ovulation has already occurred — making BBT retrospective rather than predictive. Cervical mucus observation (the Billings Ovulation Method or creighton model) tracks the changing quality of discharge from dry to egg-white consistency; peak-type mucus coincides closely with the LH surge and is a prospective indicator. Combining BBT and cervical mucus observation is the basis of the symptothermal method, with quoted effectiveness rates of 98 % or higher with perfect use.
Urine LH test strips (OPKs) detect the surge hormone approximately twelve to thirty-six hours before ovulation, providing a actionable advance warning. Digital OPKs that also measure oestrogen-to-LH ratios expand the identified fertile window and may better identify the surge in people with conditions like polycystic ovary syndrome (PCOS) where LH can be chronically elevated. Transvaginal ultrasound (follicular tracking) used in fertility clinics provides the most accurate confirmation of follicular growth and ovulation but is not practical for routine cycle awareness.
Anovulation: When Ovulation Does Not Occur
Anovulatory cycles — cycles in which menstruation occurs without ovulation — are more common than many people realise. They are normal during the first one to two years after menarche, during perimenopause, while breastfeeding, and occasionally in otherwise healthy reproductive-aged people under acute physiological stress. Pathological anovulation is associated with PCOS, hypothalamic amenorrhoea (often caused by excessive exercise, low body weight, or severe caloric restriction), hyperprolactinaemia, thyroid dysfunction, and elevated androgens.
Anovulatory cycles often look irregular on a calendar — they may be longer than usual or the luteal phase may be shortened — but can also appear superficially normal. The absence of a BBT rise or peak-type cervical mucus are useful indicators. A mid-luteal serum progesterone level (drawn seven days after expected ovulation) below 16 nmol/L (5 ng/mL) in many lab reference ranges suggests inadequate or absent ovulation. Persistent anovulation requires investigation and is among the most common and treatable causes of infertility.
Lifestyle Factors That Support or Disrupt Ovulation
The hypothalamus is exquisitely sensitive to energy availability. Chronic caloric deficits, very low body fat, and high-volume exercise training without adequate fuelling suppress GnRH pulsatility and can halt ovulation entirely — a condition called functional hypothalamic amenorrhoea (FHA). Restoration of ovulation in FHA requires weight restoration and reducing exercise load, not hormone therapy alone. This is why very lean or intensely training athletes frequently experience irregular or absent periods.
Chronic psychological stress elevates cortisol, which inhibits GnRH and can blunt the LH surge. Sleep disruption interferes with the nocturnal LH pulsatility that contributes to follicular development. Thyroid hormones directly influence ovarian responsiveness — both hypothyroidism and hyperthyroidism can disrupt the cycle. Practical ovulation-supportive habits include maintaining a body weight within a normal BMI range, prioritising seven to nine hours of quality sleep, managing stress through evidence-based strategies, and addressing any diagnosed thyroid or metabolic condition.
Frequently Asked Questions
Q: Can I ovulate more than once per cycle? A: Releasing two eggs from separate follicles (superfecundation) can occur, and this is how non-identical twins are conceived. However, both releases typically happen within a twenty-four-hour window during the LH surge. Ovulating twice in a single cycle separated by weeks, as sometimes claimed in popular media, is not supported by current reproductive physiology evidence.
Q: Does ovulation always happen on cycle day 14? A: No. Day 14 is an average derived from a textbook 28-day cycle and does not apply to most people. Ovulation can occur anywhere from day 10 to day 21 in typical cycles and even later in naturally long cycles. The luteal phase (ovulation to menstruation) is relatively constant at 12–16 days; it is the follicular phase that varies in length between people and between cycles.
Q: Can hormonal contraception delay the return of ovulation after stopping? A: Most people resume ovulation within one to three months of stopping combined oral contraceptives. A small proportion experience post-pill amenorrhoea for up to six months, typically those with a prior history of irregular cycles. The copper IUD has no hormonal effect and fertility returns immediately upon removal. If periods and ovulation do not return within three months of stopping hormonal contraception, a clinical evaluation is warranted.
Q: Is mid-cycle pain always ovulation? A: Mittelschmerz — the German term for middle pain — is a real phenomenon experienced by up to 40 % of people with ovaries, typically as a brief one-sided lower abdominal twinge or ache lasting minutes to hours around ovulation time. It is caused by follicular fluid or a small amount of blood released at ovulation irritating the peritoneum. However, one-sided pain that is severe, prolonged, or accompanied by fever or nausea is not normal ovulation pain and requires clinical evaluation to exclude ovarian torsion or cyst rupture.
Clinical Deep-Dive
Interactive companion for General / systemic. Educational only — not a diagnosis.
Understanding the relevant body system helps you notice baseline changes early and communicate clearly with a clinician.
Normal range (60–100 bpm)
Normal range (12–20 /min)
Normal range (36.1–37.2 °C)
Normal range (95–100 %)
Physical symptom checklist
- Persistent pelvic/abdominal painPossible infection or structural concern
- Unusual discharge or odorPossible infection (BV, STI, UTI)
- Skin pimples / rashes in areaIrritation, folliculitis, or infection
- Fever with urinary symptomsPossible kidney involvement
- Irregular cycle / missed periodHormonal, stress, or pregnancy related
Scientific References & Guidelines
This educational content aligns with public guidance from leading health authorities. Please consult the primary sources below for full clinical detail.
- ›World Health Organization (WHO)
- ›Centers for Disease Control and Prevention (CDC)
- ›American College of Obstetricians and Gynecologists (ACOG)
- ›The Endocrine Society — Clinical Guidelines
- ›NIH MedlinePlus — Reproductive Health
Citation reference for this article: Endocrine Society patient resources. Last medically reviewed on June 14, 2026 by Dr. Amara Rao.
Was this educational article helpful?
Medical disclaimer
This article is original educational content from Aegis Education. It is not medical advice, diagnosis, or treatment. For personal health concerns, contact a licensed healthcare professional or local emergency services when urgent care is needed.